Today's Kaposi sarcoma is not the same as it was 40 years ago, or is it?

被引:10
|
作者
Damania, Blossom [1 ,2 ]
Dittmer, Dirk P. [1 ,2 ]
机构
[1] Univ North Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, Sch Med, Dept Microbiol & Immunol, Chapel Hill, NC USA
[2] Univ North Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, Sch Med, Dept Microbiol & Immunol, 450 West Dr CB 7295,Rm 12-048, Chapel Hill, NC 27599 USA
关键词
herpesvirus; Kaposi sarcoma; KSHV; PRIMARY EFFUSION LYMPHOMA; PEGYLATED-LIPOSOMAL DOXORUBICIN; MULTICENTRIC CASTLEMAN DISEASE; INFLAMMATORY CYTOKINE SYNDROME; BLOOD MONONUCLEAR-CELLS; HIV-NEGATIVE MEN; DNA-SEQUENCES; ENDOTHELIAL-CELLS; GENE-EXPRESSION; C-MYC;
D O I
10.1002/jmv.28773
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
This review will provide an overview of the notion that Kaposi sarcoma (KS) is a disease that manifests under diverse and divergent circumstances. We begin with a historical introduction of KS and KS-associated herpesvirus (KSHV), highlight the diversity of clinical presentations of KS, summarize what we know about the cell of origin for this tumor, explore KSHV viral load as a potential biomarker for acute KSHV infections and KS-associated complications, and discuss immune modulators that impact KSHV infection, KSHV persistence, and KS disease.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Endemic Kaposi's Sarcoma
    El Zeinaty, Perla
    Lebbe, Celeste
    Delyon, Julie
    CANCERS, 2023, 15 (03)
  • [2] Oncologic Treatment of HIV-Associated Kaposi sarcoma 40 Years on
    Ramaswami, Ramya
    Lurain, Kathryn
    Yarchoan, Robert
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (03) : 294 - +
  • [3] Kaposi's Sarcoma Herpesvirus: twenty years after its discovery
    De Paoli, P.
    Carbone, A.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2016, 20 (07) : 1288 - 1294
  • [4] Kaposi's Sarcoma-Associated Herpesvirus, the Etiological Agent of All Epidemiological Forms of Kaposi's Sarcoma
    Jary, Aude
    Veyri, Marianne
    Gothland, Adelie
    Leducq, Valentin
    Calvez, Vincent
    Marcelin, Anne-Genevieve
    CANCERS, 2021, 13 (24)
  • [5] Pathology of Kaposi's sarcoma-associated herpesvirus infection
    Fukumoto, Hitomi
    Kanno, Takayuki
    Hasegawa, Hideki
    Katano, Harutaka
    FRONTIERS IN MICROBIOLOGY, 2011, 2
  • [6] Cellular origin of Kaposi's sarcoma and Kaposi's sarcoma-associated herpesvirus-induced cell reprogramming
    Cancian, Leila
    Hansen, Amy
    Boshoff, Chris
    TRENDS IN CELL BIOLOGY, 2013, 23 (09) : 421 - 432
  • [7] Immunological and Inflammatory Features of Kaposi's Sarcoma and Other Kaposi's Sarcoma-Associated Herpesvirus/Human Herpesvirus 8-Associated Neoplasias
    Riva, Giovanni
    Barozzi, Patrizia
    Torelli, Giuseppe
    Luppi, Mario
    AIDS REVIEWS, 2010, 12 (01) : 40 - 51
  • [8] Viral Profiling Identifies Multiple Subtypes of Kaposi's Sarcoma
    Hosseinipour, Mina C.
    Sweet, Kristen M.
    Xiong, Jie
    Namarika, Dan
    Mwafongo, Albert
    Nyirenda, Michael
    Chiwoko, Loreen
    Kamwendo, Deborah
    Hoffman, Irving
    Lee, Jeannette
    Phiri, Sam
    Vahrson, Wolfgang
    Damania, Blossom
    Dittmer, Dirk P.
    MBIO, 2014, 5 (05):
  • [9] KSHV downregulation of galectin-3 in Kaposi's sarcoma
    Alcendor, Donald J.
    Knobel, Susan M.
    Desai, Prashant
    Zhu, Wen Q.
    Vigil, Hollie E.
    Hayward, Gary S.
    GLYCOBIOLOGY, 2010, 20 (05) : 521 - 532
  • [10] Pathological Features of Kaposi's Sarcoma-Associated Herpesvirus Infection
    Katano, Harutaka
    HUMAN HERPESVIRUSES, 2018, 1045 : 357 - 376